Neurogastroenterology and Motility最新文献

筛选
英文 中文
Similar Tolerance of Glucagon-Like PEPTIDE-1 Agonist Therapy in Patients With Delayed and Normal Gastric Emptying. 胰高血糖素样肽-1激动剂治疗胃排空延迟和正常患者的耐受性相似。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70448
Stacey C Rolak, Tisha N Lunsford, Rosita D Frazier, Lucinda A Harris, Ming Yang, William L Hasler
{"title":"Similar Tolerance of Glucagon-Like PEPTIDE-1 Agonist Therapy in Patients With Delayed and Normal Gastric Emptying.","authors":"Stacey C Rolak, Tisha N Lunsford, Rosita D Frazier, Lucinda A Harris, Ming Yang, William L Hasler","doi":"10.1111/nmo.70448","DOIUrl":"https://doi.org/10.1111/nmo.70448","url":null,"abstract":"<p><strong>Introduction: </strong>Gastroparesis is considered a relative contraindication to glucagon-like peptide-1 receptor agonist (GLP-1RA) prescription. We examined outcomes of patients who underwent gastric scintigraphy to determine if emptying delays adversely affected tolerance of subsequent GLP-1RA therapy.</p><p><strong>Methods: </strong>Patients with delayed (DGE) and normal (NGE) gastric emptying who were subsequently prescribed GLP-1RAs were identified. GLP-1RA prescribing profiles, gastrointestinal (GI) symptoms and treatments, and GLP-1RA discontinuation were compared between patients with DGE versus NGE.</p><p><strong>Key results: </strong>Eighty-one patients were prescribed GLP-1RAs after scintigraphy; 14/81 (17%) with DGE and 67/81 (83%) with NGE. Injectable semaglutide was most often prescribed and was taken at similar doses for DGE (11/14, 79%) and NGE (40/67, 60%) (p = 0.23). GLP-1RAs were initiated a median of 386 days (IQR 190, 474) after scintigraphy with DGE versus 315 days (IQR 157, 613) with NGE (p = 0.86). GI symptoms developed in 5/14 (36%) with DGE versus 35/67 (52%) with NGE (p = 0.38) and antiemetic (p = 0.75) and prokinetic (p = 1.00) use was similar between groups. GLP-1RAs were discontinued in 45/81 (56%) patients including 14/45 (31%) for GI symptoms, which occurred similarly for DGE (3/8, 38%) and NGE (11/37, 30%) (p = 0.70). Treatment durations were similar with DGE (318 days [IQR 223, 464]) versus NGE (193 days [IQR 83, 363]) (p = 0.31).</p><p><strong>Conclusions and inferences: </strong>GLP-1RAs are taken at similar doses for similar durations, elicit similar symptoms, and are discontinued for similar reasons in patients with prior delayed versus normal gastric emptying. These observations do not support strictly avoiding GlP-1RAs in gastroparesis and suggest they may be safely prescribed in many cases.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Burden of Disorders of Gut-Brain Interaction in Nigeria: Results From the Rome Foundation Global Epidemiology Study. 尼日利亚肠脑相互作用疾病的患病率和负担:罗马基金会全球流行病学研究的结果。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70480
Abdulsalam I Aliyu, Tom van Gils, Jóhann P Hreinsson, Mary Duguru, Pantong Davwar, Michael Okorie, David Nyam, Patience Omaiye, Crystal Umejiaku, Olive Obienu, Uchenna Ijoma, Mbang Kooffreh-Ada, Kefas Zawaya, Charles Onyekwere, Adegboyega Akere, Shrikant I Bangdiwala, Hans Törnblom, Olafur S Palsson, Ami D Sperber, Edith Okeke, Magnus Simrén
{"title":"Prevalence and Burden of Disorders of Gut-Brain Interaction in Nigeria: Results From the Rome Foundation Global Epidemiology Study.","authors":"Abdulsalam I Aliyu, Tom van Gils, Jóhann P Hreinsson, Mary Duguru, Pantong Davwar, Michael Okorie, David Nyam, Patience Omaiye, Crystal Umejiaku, Olive Obienu, Uchenna Ijoma, Mbang Kooffreh-Ada, Kefas Zawaya, Charles Onyekwere, Adegboyega Akere, Shrikant I Bangdiwala, Hans Törnblom, Olafur S Palsson, Ami D Sperber, Edith Okeke, Magnus Simrén","doi":"10.1111/nmo.70480","DOIUrl":"10.1111/nmo.70480","url":null,"abstract":"<p><strong>Background: </strong>Data on the prevalence and impact of disorders of gut-brain interaction (DGBI) are lacking for most parts of Africa, including Nigeria, the country with the largest population on the continent. This study aimed to investigate the prevalence and burden of DGBI among adults in the Nigerian general population.</p><p><strong>Methods: </strong>Nigerian data from the Rome Foundation Global Epidemiology Study (RFGES) were obtained by trained interviewers using face-to-face household interviews. The questionnaire included the Rome IV diagnostic questionnaire to assess the presence of DGBI, psychological distress (PHQ-4), non-GI somatic symptom severity (PHQ-12), mental and physical quality of life (PROMIS-10), health care utilization, and dietary intake.</p><p><strong>Key results: </strong>One thousand six hundred and thirty-two individuals (48.6% females, mean age 44 (range 18-100) years) were sampled. The prevalence of any DGBI in Nigeria was 23.5% (95% CI: 21.5-25.6), with a higher prevalence in females (26.1%) than in males (21.0%). The highest prevalence of DGBI per gastrointestinal anatomical region was for bowel disorders (17.6%). The most prevalent individual DGBI diagnoses were functional dyspepsia (7.3%) and unspecified functional bowel disorder (6.6%). Compared to individuals without DGBI, individuals with DGBI were older, had reduced quality of life, increased psychological symptoms and associated healthcare utilization burden. There was a higher prevalence of any DGBI reported in the northern regions than in the southern regions.</p><p><strong>Conclusions: </strong>DGBI are prevalent and impactful in Nigeria, in line with studies from other parts of the world that utilized the face-to-face survey methodology. More studies are needed to further understand the distribution and impact of DGBI in Nigeria and other similar countries around the world where they are understudied.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13728508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyeongwi-San, a Traditional Digestant, Mitigates Proton Pump Inhibitor-Induced Dyspepsia Through Gut Microbial and Cholinergic Mechanisms in Mice. 平威山,一种传统的消化剂,通过肠道微生物和胆碱能机制减轻质子泵抑制剂诱导的消化不良小鼠。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70482
Jing-Hua Wang, Song-Yi Han, Kyung Jae Lee, Mi Young Lim, Hojun Kim
{"title":"Pyeongwi-San, a Traditional Digestant, Mitigates Proton Pump Inhibitor-Induced Dyspepsia Through Gut Microbial and Cholinergic Mechanisms in Mice.","authors":"Jing-Hua Wang, Song-Yi Han, Kyung Jae Lee, Mi Young Lim, Hojun Kim","doi":"10.1111/nmo.70482","DOIUrl":"https://doi.org/10.1111/nmo.70482","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Long-term use of proton pump inhibitors (PPIs) is frequently associated with gastrointestinal (GI) side effects, including dyspepsia, mediated through alterations in gastric pH, impaired GI motility, and gut microbiota dysbiosis. Traditional East Asian herbal formulas-Pyeongwi-san (PS), Yijung-tang (YT), and Shihosogan-tang (ST)-have long been employed clinically for GI disorders; however, their comparative efficacy and mechanistic profiles in PPI-induced GI dysfunction remain undefined.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;This study aimed to compare the therapeutic efficacy and underlying mechanisms of PS, YT, and ST in a murine model of PPI-induced GI dysfunction, with particular focus on motility, mucosal integrity, gut microbiota modulation, and relevant biomarker responses.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Male C57BL/6 mice received oral esomeprazole (160 mg/kg/day) for 4 weeks to induce dyspeptic symptoms. Concurrently, animals were administered PS, YT, or ST (1 g/kg/day), or mosapride (3 mg/kg/day) as a positive control. Outcome measures included gastric acid secretion, intragastric pH, GI motility (gastric emptying and intestinal transit), mucosal histopathology, serum and intestinal hormone levels (secretin, acetylcholine), fecal short-chain fatty acid (butyrate) concentrations, gut microbiota composition (diversity indices and taxonomic profiling), mucosal barrier gene expression (MUC2, ZO-1, Occludin), proinflammatory cytokines (IL-1β, TNF-α), and H&lt;sup&gt;+&lt;/sup&gt;/K&lt;sup&gt;+&lt;/sup&gt;-ATPase protein expression.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Esomeprazole reliably suppressed gastric acid secretion, elevated intragastric pH, impaired GI motility, induced mucosal injury, and caused gut microbiota dysbiosis. Among the three herbal formulas tested, PS showed significant improvements across a broader range of measured endpoints relative to the PPI group. PS significantly improved gastric emptying and intestinal transit times (p &lt; 0.05 vs. PPI group), whereas mosapride improved gastric emptying but showed no significant effect on intestinal transit. It further elevated serum secretin, intestinal acetylcholine, and fecal butyrate levels (p &lt; 0.05 vs. PPI group); restored gut microbiota alpha-diversity; and upregulated mucosal barrier genes. PS also suppressed proinflammatory cytokine expression and modulated H&lt;sup&gt;+&lt;/sup&gt;/K&lt;sup&gt;+&lt;/sup&gt;-ATPase protein expression, indicative of integrated gastroprotective and prokinetic mechanisms. YT and ST also showed significant effects on selected endpoints.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;PS most effectively attenuated PPI-induced GI dysfunction through a multi-target mechanism encompassing prokinetic activity, gut microbiota restoration, mucosal barrier reinforcement, and immunomodulatory regulation of key hormones and cytokines. These findings position PS as a promising botanical candidate for the management of PPI-related dyspepsia, warranting further investigation in controlled clin","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EGJOO: Reflections on Recent Evidence, Current Gaps, and the Path Ahead. EGJOO:对近期证据、当前差距和未来道路的反思。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70484
Edoardo Vespa
{"title":"EGJOO: Reflections on Recent Evidence, Current Gaps, and the Path Ahead.","authors":"Edoardo Vespa","doi":"10.1111/nmo.70484","DOIUrl":"https://doi.org/10.1111/nmo.70484","url":null,"abstract":"","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149299249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Padova Classification: Shared Priorities for Validation and Clinical Integration-Response to Letter to the Editor. 帕多瓦分类:验证和临床整合的共享优先级-致编辑信的回应。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70504
Renato Salvador, Arianna Vittori, Giovanni Capovilla, Matteo Santangelo, Luca Provenzano, Francesca Forattini, Matteo Pittacolo, Michele Valmasoni
{"title":"The Padova Classification: Shared Priorities for Validation and Clinical Integration-Response to Letter to the Editor.","authors":"Renato Salvador, Arianna Vittori, Giovanni Capovilla, Matteo Santangelo, Luca Provenzano, Francesca Forattini, Matteo Pittacolo, Michele Valmasoni","doi":"10.1111/nmo.70504","DOIUrl":"https://doi.org/10.1111/nmo.70504","url":null,"abstract":"","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting the Gut-Brain Axis in Functional Dyspepsia: Buspirone and Mirtazapine Improve Anxiety and PAGI-SYM Scores. 针对功能性消化不良的肠-脑轴:丁螺环酮和米氮平改善焦虑和PAGI-SYM评分。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70479
Mahdieh Khorashadizadeh, Fatemeh Salmani, Tahmine Tavakoli
{"title":"Targeting the Gut-Brain Axis in Functional Dyspepsia: Buspirone and Mirtazapine Improve Anxiety and PAGI-SYM Scores.","authors":"Mahdieh Khorashadizadeh, Fatemeh Salmani, Tahmine Tavakoli","doi":"10.1111/nmo.70479","DOIUrl":"10.1111/nmo.70479","url":null,"abstract":"<p><strong>Background: </strong>Functional dyspepsia is a chronic gastrointestinal disorder with uncertain causes, often linked to anxiety and depression, which can worsen symptoms and hinder treatment success. Although psychological therapies and antidepressants have shown some benefit, the role of anti-anxiety medications remains unclear. This study aims to evaluate the effectiveness of buspirone and mirtazapine in reducing symptoms and improving the quality of life for patients with functional dyspepsia.</p><p><strong>Methods: </strong>In a semi experimental study, 71 patients with functional dyspepsia were randomized to receive either buspirone 15 mg, mirtazapine 7.5 mg, or pantoprazole 40 mg once daily for 12 weeks. Outcomes-anxiety severity, dyspepsia symptom score, quality of life, and adverse events-were assessed at baseline and monthly. Efficacy was analyzed by repeated-measures ANOVA and adverse event rates by chi-square tests.</p><p><strong>Results: </strong>Both buspirone and mirtazapine significantly outperformed pantoprazole alone in reducing anxiety (buspirone vs. control at 3 months, p = 0.01; both active treatments vs. control, p < 0.05) and in alleviating functional dyspepsia symptoms by Week 12 (both vs. control, p < 0.05), with no difference between the two active drugs.</p><p><strong>Conclusions: </strong>This study suggests that buspirone and mirtazapine are effective in reducing anxiety and improving symptoms in patients with functional dyspepsia. These findings highlight the potential role of anti-anxiety medications in managing both the psychological and gastrointestinal aspects of this disorder.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticipated Threat Amplifies Esophageal Perception in the Absence of Peripheral Change. 在没有外周变化的情况下,预期威胁会放大食管感知。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70503
Livia Guadagnoli, Jonas Zaman, Jutta Windey, Dimitri van Ryckeghem, Stefaan Van Damme, Lukas Van Oudenhove
{"title":"Anticipated Threat Amplifies Esophageal Perception in the Absence of Peripheral Change.","authors":"Livia Guadagnoli, Jonas Zaman, Jutta Windey, Dimitri van Ryckeghem, Stefaan Van Damme, Lukas Van Oudenhove","doi":"10.1111/nmo.70503","DOIUrl":"10.1111/nmo.70503","url":null,"abstract":"<p><strong>Background: </strong>Psychological processes may influence how gastrointestinal sensations are perceived and responded to, but their impact on esophageal symptom perception remains poorly understood. We developed and tested a novel stimulus-response paradigm to examine how anticipated threat influences behavioral responding, fear, and perceived intensity of esophageal sensations.</p><p><strong>Methods: </strong>Healthy volunteers detected and rated neutral electrical stimulations to the distal esophagus under anticipated threat (potential pain) and control (no pain) conditions, pressing a response button (reaction time) and rating intensity and fear after each stimulus. To evaluate specificity, the paradigm was also applied to somatic hand stimulation. Linear mixed-effects models tested whether threat produced shorter reaction times and heightened fear and intensity ratings, and whether these effects differed by body location.</p><p><strong>Key results: </strong>The sample included 46 participants. Participants rated stimuli in the threat condition as more intense and fear-evoking than control stimuli (both p < 0.0001), despite the stimuli being physically identical. Fear ratings were higher for esophageal than hand stimulation (p < 0.0001). Contrary to our hypothesis, response times were slower under threat (p = 0.0003) and for esophageal versus hand stimulation (p < 0.0001). Threat effects across all outcomes did not differ by body location p, suggesting a more general effect of threat across visceral and somatic stimulation.</p><p><strong>Conclusions & inferences: </strong>Threat amplified perceived intensity and fear in response to neutral esophageal stimulation. Contrary to expectations, response times were slower under threat, suggesting threat may potentially interfere with rather than facilitate behavioral responding. These findings support a role for threat-related processes in esophageal symptom perception.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13756556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anorectal Manometry and Balloon Expulsion Testing in Chronic Constipation: Concordance, Manometric Predictors of Dyssynergic Defecation, and Implications for Biofeedback Referral. 慢性便秘的肛肠测压和气囊排出试验:一致性,排便失调的测压预测因素,以及对生物反馈转诊的影响。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70485
Orrin Wilson, Jason Goldenberg, Zachary Wilmer Reichenbach, Henry P Parkman
{"title":"Anorectal Manometry and Balloon Expulsion Testing in Chronic Constipation: Concordance, Manometric Predictors of Dyssynergic Defecation, and Implications for Biofeedback Referral.","authors":"Orrin Wilson, Jason Goldenberg, Zachary Wilmer Reichenbach, Henry P Parkman","doi":"10.1111/nmo.70485","DOIUrl":"https://doi.org/10.1111/nmo.70485","url":null,"abstract":"<p><strong>Background: </strong>Anorectal manometry (ARM) and the balloon expulsion test (BET) are recommended for evaluating dyssynergic defecation, but neither is a reference standard. We quantified ARM-BET concordance across four categories defined by the Rao pattern and BET result and tested whether continuous physiologic measures predict BET better than the Rao classification.</p><p><strong>Methods: </strong>We reviewed 133 consecutive high-resolution ARM studies (modified London Protocol) in patients referred for chronic constipation. Seated BET (50 mL, abnormal > 60 s) followed ARM. Concordance used Cohen's kappa and McNemar's test. The rectoanal gradient and defecation index were tested against BET, and multivariable regression against dyssynergic pattern.</p><p><strong>Key results: </strong>Of 133 patients (100 women, mean age 46), 84 (63%) had a dyssynergic pattern and 54 (41%) a prolonged BET. Agreement was slight (56%, kappa 0.17): 30% were abnormal on both tests, 44% on one test, and 26% normal on both. The rectoanal gradient predicted abnormal BET better than the Rao classification; among dyssynergic-pattern patients an abnormal BET was associated with a more negative gradient (-29 vs. -3 mmHg, p = 0.001). Lower resting anal sphincter pressure was independently associated with the dyssynergic pattern (adjusted odds ratio 0.50 per 10 mmHg) but not BET. Biofeedback improved symptoms in 19 of 21 patients.</p><p><strong>Conclusions and inferences: </strong>ARM-BET agreement is slight, and either test alone misclassifies patients. Continuous physiologic measures discriminate evacuation better than the Rao classification and account for much of the discordance. Lower resting pressure characterizes the dyssynergic phenotype without predicting evacuation. Biofeedback response was high if either test was positive.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking Superior Mesenteric Artery Syndrome: Insights Into Diagnosis and Therapeutic Strategies. 重新思考肠系膜上动脉综合征:诊断和治疗策略的见解。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70497
Christian von Muhlenbrock, Sandrien Abbeel, Thomas Debrouwere, Dirk Vanbeckevoort, Jan Tack, Tim Vanuytsel
{"title":"Rethinking Superior Mesenteric Artery Syndrome: Insights Into Diagnosis and Therapeutic Strategies.","authors":"Christian von Muhlenbrock, Sandrien Abbeel, Thomas Debrouwere, Dirk Vanbeckevoort, Jan Tack, Tim Vanuytsel","doi":"10.1111/nmo.70497","DOIUrl":"https://doi.org/10.1111/nmo.70497","url":null,"abstract":"<p><strong>Background: </strong>The superior mesenteric artery (SMA) syndrome is reported as a rare cause of intestinal obstruction caused by vascular compression of the third part of the duodenum between the aorta and the SMA. Both medical and surgical treatments have been proposed, with different reported success rates. Our aim is to assess the clinical features, imaging findings, and treatment outcomes of patients undergoing hypotonic barium duodenography (HBD) for suspected SMA syndrome and evaluate the effectiveness of medical and surgical treatments.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of patients undergoing HBD for suspected SMA syndrome. HBD findings were compared with CT measurements of aortomesenteric distance (AMD) and angle (AMA). Results of antroduodenal manometry and gastric emptying tests were analyzed. Clinical outcomes were compared between medical and surgical management.</p><p><strong>Key results: </strong>Forty-nine patients underwent HBD (33.2 ± 1.6 years; 84% female; BMI 17.5 kg/m<sup>2</sup>) between 2003 and 2023. After excluding patients with a more likely alternative diagnosis, 11 patients met the predefined HBD criteria for SMA syndrome. Clinical characteristics did not differ between confirmed cases and the non-confirmed patients (controls). AMA was significantly sharper in cases (18.8 ± 2.5 vs. 26.5 ± 2.1; p = 0.05), while AMD was similar (5 ± 2.2 vs. 7 ± 2.2 mm; p = 0.13). In the confirmed group, medical therapy (n = 6) led to weight gain in 67% and symptom improvement in 50%; surgery (n = 5) resulted in weight gain in 80% but symptom relief in only one patient (20%).</p><p><strong>Conclusions: </strong>Conservative management should be the initial approach in suspected SMA syndrome. Careful diagnosis combined with structured medical therapy can yield clinical benefit while avoiding surgical risks. Prospective studies are needed to refine criteria for intervention.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbiota From Human Infants Consuming Secretors Mothers' Milk Affects Murine Intestinal Motility and Enteric Nervous System Development in a Sex-Dependent Manner. 食用母乳的人类婴儿的微生物群以性别依赖的方式影响小鼠肠道运动和肠神经系统的发育。
IF 3 3区 医学
Neurogastroenterology and Motility Pub Date : 2026-11-01 DOI: 10.1111/nmo.70475
Bharath K Kumar, Valentina Caputi, Kirandeep K Gill, Bindu Nanduri, Tanya Leroith, Renee Fox, Fernanda Rosa, Joshua M Lyte, Laxmi Yeruva
{"title":"Microbiota From Human Infants Consuming Secretors Mothers' Milk Affects Murine Intestinal Motility and Enteric Nervous System Development in a Sex-Dependent Manner.","authors":"Bharath K Kumar, Valentina Caputi, Kirandeep K Gill, Bindu Nanduri, Tanya Leroith, Renee Fox, Fernanda Rosa, Joshua M Lyte, Laxmi Yeruva","doi":"10.1111/nmo.70475","DOIUrl":"10.1111/nmo.70475","url":null,"abstract":"<p><strong>Background: </strong>Early life is a critical period in which the gut microbiome and the enteric nervous system (ENS) develop together, shaping long-term gastrointestinal (GI) function. Human milk feeding and particularly maternal secretor phenotype strongly influence early microbiome composition. However, how human milk promoted microbiomes impact ENS development is still largely unknown.</p><p><strong>Methods: </strong>Male and female juvenile (three weeks old) C57BL/6 germ-free mice were colonized with fecal microbiota from infants whose mothers were secretors (SMM, 2-fucosyl lactose in milk) or non-secretors (NSM) or from infants consuming cow's milk formula (MFM). Non-transplanted male and female germ-free mice served as controls. GI transit was assessed at post-natal day 35-37. ENS neuronal and glial organization was evaluated in full-thickness colon preparations using immunohistochemistry and confocal microscopy.</p><p><strong>Key results: </strong>Female germ-free mice receiving SMM exhibited higher distal GI transit efficiency and a higher proportion of nitrergic neurons in the myenteric plexus compared to sex-matched controls and to males. Choline acetyltransferase (ChAT; marker for excitatory cholinergic neurons) immunoreactivity was higher in the myenteric ganglia of germ-free female compared to male mice. ChAT immunoreactivity increased in SMM and MFM males, while it was significantly reduced in NSM and MFM females compared to controls. Infant microbiomes did not affect myenteric glial cells, which were more abundant in males than females across all groups.</p><p><strong>Conclusions and inferences: </strong>Our findings demonstrate that early-life maternal secretor-associated infant microbiomes exert sex-specific effects on ENS neuronal phenotypes and GI motility, underlying a previously unrecognized link between infant-derived microbiomes and ENS development that warrants investigation in larger cohorts.</p>","PeriodicalId":19123,"journal":{"name":"Neurogastroenterology and Motility","volume":"38 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书